Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells
Journal Article
·
· PLoS Computational Biology (Online)
- Univ. of Bern (Switzerland). Inst. of Social and Preventative Medicine (ISPM); DOE/OSTI
- Univ. Hospital of Zurich (Switzerland). Div. of Infectious Diseases and Hospital Epidemiology
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Div.
- Imperial College, London (United Kingdom)
HIV-1-infected cells in peripheral blood can be grouped into different transcriptional subclasses. Quantifying the turnover of these cellular subclasses can provide important insights into the viral life cycle and the generation and maintenance of latently infected cells. We used previously published data from five patients chronically infected with HIV-1 that initiated combination antiretroviral therapy (cART). Patient-matched PCR for unspliced and multiply spliced viral RNAs combined with limiting dilution analysis provided measurements of transcriptional profiles at the single cell level. Furthermore, measurement of intracellular transcripts and extracellular virion-enclosed HIV-1 RNA allowed us to distinguish productive from non-productive cells. We developed a mathematical model describing the dynamics of plasma virus and the transcriptional subclasses of HIV-1-infected cells. Fitting the model to the data allowed us to better understand the phenotype of different transcriptional subclasses and their contribution to the overall turnover of HIV-1 before and during cART. The average number of virus-producing cells in peripheral blood is small during chronic infection. We find that a substantial fraction of cells can become defectively infected. Assuming that the infection is homogenous throughout the body, we estimate an average in vivo viral burst size on the order of 104 virions per cell. Our study provides novel quantitative insights into the turnover and development of different subclasses of HIV-1-infected cells, and indicates that cells containing solely unspliced viral RNA are a good marker for viral latency. The model illustrates how the pool of latently infected cells becomes rapidly established during the first months of acute infection and continues to increase slowly during the first years of chronic infection. Having a detailed understanding of this process will be useful for the evaluation of viral eradication strategies that aim to deplete the latent reservoir of HIV-1.
- Research Organization:
- Los Alamos National Lab., NM (United States)
- Sponsoring Organization:
- Abbott Inc.; National Institutes of Health (NIH); Novartis Foundation; Roche Research Foundation; Swiss National Science Foundation (SNSF); USDOE National Nuclear Security Administration (NNSA)
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 1627240
- Journal Information:
- PLoS Computational Biology (Online), Journal Name: PLoS Computational Biology (Online) Journal Issue: 10 Vol. 10; ISSN 1553-7358
- Publisher:
- Public Library of ScienceCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells
Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells
A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”
Journal Article
·
Sat Nov 14 23:00:00 EST 2015
· Virology
·
OSTI ID:22581645
Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells
Journal Article
·
Thu Oct 22 20:00:00 EDT 2015
· PLoS Pathogens
·
OSTI ID:1235937
A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”
Journal Article
·
Sun Aug 20 20:00:00 EDT 2017
· Scientific Reports
·
OSTI ID:1390617